Revised SPC: Neulasta (pegfilgrastim)

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
29 November 2019

Abstract

SPC contains warnings on Stevens-Johnson syndrome, a rare but life-threatening or fatal adverse event. Treatment should be discontinued in affected patients.